STING1 and cancer: Two major hypotheses have been prompted for the DC activation by cancer cells: tumor-derived DNA activates the DCs [31], or tumor-derived cGAMP directly activates the STING pathway via protein STING [25], thereby leading to the production of type I IFNs.